Realbotix Reports that Potential US-Canada Tariffs Pose Insignificant Risk
Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, provides an update that potential US-Canada tariffs would have an insignificant impact on its operations.On February 2, 2025, the US and Canada respectively announced a 25-per-cent tariff to be imposed on goods imported and exported between the two countries, effective February 4, 2025. The two governments later announced that the tariffs would be paused for 30 days.The Company notes, 100% of its manufacturing and sales originate from the US, and sales to Canadian customers accounted for approximately 3% of Realbotix’s total sales in 2024. Therefore, regardless of the outcome of the tariffs, the Company expects an insignificant impact to its operations.The Company continues to monitor the trade situation, and should any further material developments occur that could potentially impact our business, will promptly update the market, our customers, and investors.
Pharmaaktien machen Pharmadinge#PV3B(A2QJRU)
7,90 +8,1%
(ohne News 
5.17$ 
